OS Therapies Incorporated

Healthcare · Biotechnology · United States

Last price 1.24 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 57.29M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company’s pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. The company was incorporated in 2018 and i...